Peter McAllister, MD

Peter McAllister, MD,

Neurologist and clinical investigator Peter McAllister, MD, is eager to make progress in research on diagnosis and treatment and to hear more patient voices.

Migraine expert Peter McAllister, MD, a long-time principal investigator for migraine studies, wonders if study design in this area needs to be re-evaluated.

"This AHS statement has exceeded our wildest dreams..." McAllister said of the impact of the society recommendation that CGRP inhibitors be considered among first-line treatment for migraine.

Significant strides were made in 2024 in evaluating a wide range of treatments for migraine, including phase 2 findings with PACAP inhibition, PI McAllister said.

The onset of migraine with its wide range of symptoms may be telegraphed as early as 2 days before by the frequency of neuronal oscillation deep in the brain.

Headache is a common complaint in primary care--and sometimes it presents full-blown. You can rescue the patient in distress by keeping 5 common injectables on hand. 

Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?  

Early diagnosis of cluster headache, commonly considered the most painful condition on earth, is essential to curbing disability; here's what primary care clinicians need to know. 

Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.

Injectable medications for migraine are effective, inexpensive, and easy to store. Try these 5 questions on 5 you may want to have on hand.

Neuromodulation to treat migraine and other primary headaches is proven effective in clinical trials and may be an option for your patients looking for drug-free relief.

Headache diagnosis can be "a pain" all year 'round, but particularly irksome when you have summer plans. Neurologist Peter McAllister, MD, serves up some apps to help with that.

Monoclonal antibodies that inhibit calcitonin gene-related peptide could revolutionize preventive migraine therapy. Here's what you need to know.